Neurogen has appointed Dr. John LaMattina, former head of global research and development at Pfizer, to its board of directors.

Concentric Pharma Advertising promoted Aimee Eastwood to associate creative director, copy. Eastwood was previously group copy director.

MedThink Communications has been retained by Salix Pharmaceuticals to launch and promote its newest product under development, an orally disintegrating form of metoclopramide.

The FDA has delayed approval of GlaxoSmithKline and SkyePharma's reformulated Requip XL (ropinirole) as a treatment for Parkinson's disease.

OrthoNeutrogena, a division of Ortho-McNeil Pharmaceuticals, has selected Stratagem Healthcare Communications to handle the company's marketing and branding initiatives for Renova (tretinoin cream 0.02%) indicated to reduce fine facial lines associated with chronic sun exposure when used as part of a comprehensive skin care program.

GlaxoSmithKline has inked a deal worth as much as $425 million to develop drugs for respiratory and cardiovascular disease with San Diego company Amira Pharmaceuticals.

Solvay Pharmaceuticals CEO Laurence Downey, MD, will retire effective April 30th and will be succeeded by Stephen Hill, the Marietta, GA, firm said in a statement.

Allergan awarded Pacific Communications the DTC assignment for its severe axillary hyperhidrosis (severe underarm sweating) indication on Botox following a competitive pitch.

Project X-Ray and Area 23, two Manhattan agencies that spun out of Interpublic Group's Draftfcb Healthcare unit last year, are merging.

Merck/Schering-Plough launched patient education ads for Vytorin and Zetia in newspapers over the weekend while temporarily suspending broadcast advertising for the brands.